Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

PUBLIC PAGE
Mon, Jul 29 8:41am

IBD: A Comorbidity of PSC

By Konstantinos N. Lazaridis, M.D., @klazaridis

 

IBD graphic

The majority of patients with the PSC have Inflammatory Bowel Disease (IBD). The association of those two diseases is known for decades, yet the contribution of IBD in the development and outcomes of PSC remain sunclear. Morever, the presence of IBD among patients with PSC affects the medical and surgical management of these patients. Patients with PSC should understand the relationship and  impact of IBD on PSC.

In this presentation, Dr. Laura Raffals, Associate Professor of Medicine, Mayo Clinic College of Medicine provides a comprehensive review of the epidemiology, diagnosis, outcomes and management of IBD among PSC patients.

View the powerpoint presentation from Dr. Raffals

Join others discussing PSC

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

Please login or register to send an invite.